Hopebridge Faced Investigation Into Care and Billing
A new investigative report raises concerns about business practices and patient care at autism therapy centers.
Updated on Oct. 9, 2026 in Autism
Live Poll
Do you trust private equity-owned firms to provide high-quality medical care to children?
The American Accountability Foundation recently published a 33-page report detailing concerns regarding Hopebridge, a provider operating more than 100 autism therapy centers. The investigation into the company, which was acquired by Arsenal Capital Partners in 2019, highlights multiple federal settlements and ongoing scrutiny of its clinical quality.
Why it matters
The report underscores growing federal concern over the quality of Applied Behavior Analysis (ABA) services as national spending on these treatments has surged. Families and caregivers are increasingly evaluating how rapid growth in the sector may influence the consistency of clinical practices.
An investigation by the American Accountability Foundation cites a 421% increase in ABA service spending between 2021 and 2025, alongside specific legal settlements including a $300,000 wage case and a federal civil penalty. The findings reflect aggregated data from court records, billing audits, and incident reports.
The players
American Accountability Foundation
An organization that conducts investigations into corporate practices and government transparency.
Hopebridge
A private provider operating over 100 centers that specialize in autism therapy services.
Arsenal Capital Partners
A private equity firm that acquired Hopebridge in 2019.
Centers for Medicare and Medicaid Services
The federal agency responsible for managing health insurance programs and oversight of ABA service expenditures.
The details
The report alleges that Hopebridge prioritizes investor returns over the delivery of consistent patient care. The company relies on a model that employs technicians to deliver services, a structure that has drawn criticism regarding the quality of patient oversight and treatment plan standardization. These concerns are amplified by reported incidents, including instances of abuse and improper billing practices documented in legal filings.
Timeline
May 2019: A child was allegedly left unattended at a Bloomington center.
March 2021: A lawsuit alleged the company charged $37,000 for deficient services.
February 2023: A federal judge approved a $300,000 wage case settlement in Ohio.
October 31, 2025: The Department of Health and Human Services listed an enforcement action against Hopebridge.
Health Landscape
This investigation occurs against the backdrop of a 421% increase in federal ABA service spending reported by the Centers for Medicare and Medicaid Services since 2021. It highlights a broader shift in autism care as private equity-backed models face mounting pressure to balance investor goals with clinical standards.
Families receiving ABA therapy may want to review the consistency of their child's treatment plans and confirm the credentials of the technicians providing direct care. It is always appropriate to raise questions about clinical oversight and facility incident reporting policies with your provider.
The takeaway
The recent investigation highlights the importance of monitoring the quality and consistency of therapy services, especially in rapidly growing care networks. Parents and caregivers should maintain open communication with their clinical teams and feel empowered to request detailed updates on treatment supervision protocols.
Further reading
For more on navigating clinical standards and advocacy, visit Autism.
Source note: This article includes information reported by Washington Examiner.
Live Poll
Do you trust private equity-owned firms to provide high-quality medical care to children?
